MSCI ACWI IMI Virology Index

The MSCI ACWI IMI Virology Index is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The index aims to represent the performance of a set of companies that are associated with research and development into, as well as the commercialization of anti-viral and vaccine products, which are used to treat a range of infectious diseases.
Index code
748382
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.46
P/E
37.98
P/E Fwd
23.80
P/BV
2.62
Number of constituents
41
Index Market Cap
$3.24 T
Largest constituent Market Cap
$211.97 B
Smallest constituent Market Cap
$4.46 B
Average constituent Market Cap
$79.14 B
Median constituent Market Cap
$41.74 B
Does this benchmark pursue ESG objectives?
No
Data as of April 30, 2025 

Want to learn more about MSCI indexes?
Get in touch.